Valperinol
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
(1R,3R,4S,6R,7S,8R,10R)-8-methoxy-10-methyl-3-(1-piperidinylmethyl)-2,9-dioxatricyclo[4.3.1.03,7]decan-4-ol | |
Clinical data | |
Legal status | Non-regulated |
Identifiers | |
CAS number | 64860-67-9 |
ATC code | None |
PubChem | CID 68849 |
ChemSpider | 62082 |
Chemical data | |
Formula | C16H27NO4 |
Mol. mass | 297.390 g/mol |
SMILES
| |
| |
Valperinol (INN; GA 30-905) is a drug which acts as a calcium channel blocker.[1][2] It was patented as a possible sedative, antiepileptic, and/or antiparkinsonian agent, but was never marketed.[3]
References
- ↑ Thies PW, Asai A, Bán I, David S, Finner E (1984). "[The synthesis of valperinol and various 3-aminomethyl derivatives of 2,9-dioxatricyclo[4,3,1,0(3,7)]decane from didrovaltrate]". Arzneimittel-Forschung (in German) 34 (11): 1460–3. PMID 6543120.
- ↑ Dose M (1984). "[Calcium antagonist properties of valperinol]". Arzneimittel-Forschung (in German) 34 (11): 1464–6. PMID 6098282.
- ↑ Dictionary of Pharmacological Agents Volume 2. CRC Press. p. 2104. ISBN 978-0-412-46630-4. Retrieved 22 April 2012.
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.